Adeline Bouard

588 total citations
17 papers, 396 citations indexed

About

Adeline Bouard is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Adeline Bouard has authored 17 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Adeline Bouard's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Adeline Bouard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Adeline Bouard collaborates with scholars based in France, Belgium and United States. Adeline Bouard's co-authors include Christophe Borg, Jean‐René Pallandre, Olivier Adotévi, Jérémy Balland, Paul Peixoto, Yann Godet, Virginie Mougey, Éric Hervouet, Arulraj Nadaradjane and Marine Jary and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Cancer.

In The Last Decade

Adeline Bouard

16 papers receiving 391 citations

Peers

Countries citing papers authored by Adeline Bouard

Since Specialization

Citations

This map shows the geographic impact of Adeline Bouard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adeline Bouard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adeline Bouard more than expected).

Fields of papers citing papers by Adeline Bouard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adeline Bouard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adeline Bouard. The network helps show where Adeline Bouard may publish in the future.

Co-authorship network of co-authors of Adeline Bouard

This figure shows the co-authorship network connecting the top 25 collaborators of Adeline Bouard. A scholar is included among the top collaborators of Adeline Bouard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adeline Bouard. Adeline Bouard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo‐refractory gastrointestinal cancers 2025 ·International Journal of Cancer ·Laurie Spehner, Adeline Bouard, (unknown), Marie Kroemer, Stéfano Kim, Thierry Nguyen, (unknown), Francine Fein, (unknown), Romain Loyon, Christophe Borg, Angélique Vienot	0
2	Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT Trials 2025 ·Cancer Research Communications ·Angélique Vienot, Déwi Vernerey, Adeline Bouard, (unknown), Stéfano Kim, Christophe Tournigand, Christophe Louvet, Thierry André, Benoı̂t Rousseau, (unknown), Laurie Spehner, Ying A. Wang, (unknown), (unknown), Christophe Borg	2
3	Liver metastases of colorectal cancer contain different subsets of tissue-resident memory CD8 T cells correlated with a distinct risk of relapse following surgery 2025 ·OncoImmunology ·(unknown), Alexandre Doussot, Marie Kroemer, Eve Laloy, Jean‐René Pallandre, (unknown), Laurie Spehner, (unknown), Adeline Bouard, Virginie Mougey, (unknown), Angélique Vienot, (unknown), Zaher Lakkis, Franck Monnien, Romain Loyon, Christophe Borg	3
4	AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies 2025 ·Frontiers in Immunology ·Astrid Musnier, (unknown), A. Verdier, Mélanie Cortès, Jean‐René Pallandre, (unknown), Adeline Bouard, (unknown), (unknown), (unknown), Anne Poupon, Thomas Bourquard	2
5	SALL4 ‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features 2023 ·Molecular Oncology ·Angélique Vienot, Franck Monnien, Caroline Truntzer, Virginie Mougey, Adeline Bouard, Jean‐René Pallandre, (unknown), Romain Loyon, (unknown), Gerlinde Avérous, François Ghiringhelli, Frédéric Bibeau, Paul Peixoto, Christophe Borg	5
6	The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age 2023 ·Frontiers in Immunology ·(unknown), Laurie Spehner, Luigi Mansi, Adeline Bouard, Alexandre Falcoz, Quentin Lepiller, (unknown), (unknown), Angélique Vienot, Marie Kroemer, Christophe Borg	2
7	A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study 2022 ·Frontiers in Oncology ·(unknown), Angélique Vienot, Olivier Adotévi, Marion Jacquin, François Ghiringhelli, Christelle de la Fouchardière, Benoît You, Tristan Maurina, Elsa Kalbacher, Fernando Bazán, (unknown), (unknown), (unknown), Laurie Spehner, Adeline Bouard, Déwi Vernerey, Aurélia Meurisse, Stéfano Kim, Christophe Borg, Laura Mansi	20
8	Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy 2022 ·OncoImmunology ·Angélique Vienot, Jean‐René Pallandre, (unknown), (unknown), Adeline Bouard, Laurie Spehner, Marie Kroemer, (unknown), Bas van der Woning, Hans de Haard, Romain Loyon, Éric Hervouet, Paul Peixoto, Christophe Borg	20
9	Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients 2021 ·European Journal of Cancer ·Laura Mansi, Laurie Spehner, Étienne Daguindau, Kévin Bouiller, Hamadi Almotlak, Ulrich Stein, Adeline Bouard, Stéfano Kim, (unknown), Marine Jary, (unknown), Angélique Vienot, Charlée Nardin, Fernando Bazán, Quentin Lepiller, Virginie Westeel, Olivier Adotévi, Christophe Borg, Marie Kroemer	17
10	Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases 2020 ·Journal for ImmunoTherapy of Cancer ·Marie Kroemer, Célia Turco, Laurie Spehner, (unknown), (unknown), Adeline Bouard, (unknown), Marina Deschamps, Yann Godet, Olivier Adotévi, Samuel Limat, Bruno Heyd, Marine Jary, Romain Loyon, Christophe Borg	31
11	Molecular description of ANGPT2 associated colorectal carcinoma 2020 ·International Journal of Cancer ·Marine Jary, (unknown), Angélique Vienot, (unknown), Romain Loyon, (unknown), Adeline Bouard, (unknown), (unknown), Stéfano Kim, (unknown), (unknown), Olivier Adotévi, Olivier Bouché, Thierry Lecomte, Christophe Borg, Jean Paul Feugeas	22
12	Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer 2019 ·Cancer Immunology Research ·Elodie Lauret Marie Joseph, Caroline Laheurte, Marine Jary, Laura Boullerot, (unknown), (unknown), Adeline Bouard, (unknown), Magalie Dosset, Christophe Borg, Olivier Adotévi	33
13	PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma 2018 ·OncoImmunology ·(unknown), (unknown), Yann Godet, Paul Peixoto, Arulraj Nadaradjane, Michaël Boyer‐Guittaut, Jeanne Galaine, David Guenat, Virginie Mougey, Jérôme Perrard, Jean‐René Pallandre, Adeline Bouard, Jérémy Balland, (unknown), Olivier Adotévi, Elodie Hendrick, Michaël Herfs, Pierre‐François Cartron, Christophe Borg, Éric Hervouet	158
14	A new anti-mesothelin antibody targets selectively the membrane-associated form 2017 ·mAbs ·(unknown), Jérémy Balland, (unknown), Adeline Bouard, Virginie Mougey, (unknown), (unknown), (unknown), Marine Jary, Stéfano Kim, María González-Pajuelo, Bernard Royer, Hans de Haard, Andrew R. Clark, John Wijdenes, Christophe Borg	6
15	ARGX-111 shows activity in MET-amplified patients in a phase-I study and in preclinical models of myeloid-derived suppressor cell (MDSC) depletion in the tumor microenvironment. 2016 ·Journal of Clinical Oncology ·Christian Rolfo, Philippe Aftimos, Jean‐René Pallandre, Virginia Morello, Adeline Bouard, (unknown), Philippe Barthélémy, Sylvie Rottey, Ahmad Awada, Valérie Hanssens, Natalie De Jonge, Luc Van Rompaey, (unknown), Paolo Michieli, Christophe Borg	1
16	Neuropilin-2 Expression Promotes TGF-β1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells 2011 ·PLoS ONE ·Camille Grandclément, Jean‐René Pallandre, (unknown), É. Viel, Adeline Bouard, Jérémy Balland, Jean-Paul Rémy-Martin, B. Simon, Alain Rouleau, Wilfrid Boireau, Michael Klagsbrun, Christophe Ferrand, Christophe Borg	73
17	Neuropilin-2 and epithelial to mesenchymal transition in colorectal cancer cells. 2010 ·Journal of Clinical Oncology ·Camille Grandclément, Romain Bedel, B Kantelip, Adeline Bouard, Virginie Mougey, Michael Klagsbrun, Christophe Ferrand, Pierre Tiberghien, Xavier Pivot, Christophe Borg	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact